Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma

Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study

Jeeyun Lee, Cheolwon Suh, Young Hyeh Ko et al. · Journal of Clinical Oncology · 2005 · 614 citations · Full text

Medicine, Oncology, Cancer Immunology +12

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Motoko Yamaguchi, Yok‐Lam Kwong, Won Seog Kim et al. · Journal of Clinical Oncology · 2011 · 602 citations

Pharmacy, Oncology, Pharmacotherapy +13

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

Arnaud Jaccard, Nathalie Gachard, Benôıt Marin et al. · Blood · 2010 · 386 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

Wyndham H. Wilson, G Bryant, Susan E. Bates et al. · Journal of Clinical Oncology · 1993 · 246 citations

Medicine, Oncology, Pharmacology +17

First‐line combination of gemcitabine, oxaliplatin, and L‐asparaginase (GELOX) followed by involved‐field radiation therapy for patients with stage IE/IIE extranodal natural killer/T‐cell lymphoma

Liang Wang, Zhi‐Hui Wang, Ya‐jun Li et al. · Cancer · 2012 · 202 citations

Medicine, Oncology, Radiation Oncology +14